FDA Clearance Tracker · P950014-S023
PROSTATRON
Last checked: Nov 20, 2026Latest source record: Feb 18, 2005 (this decision)Source: openFDAMethods & limitations
Decided
Feb 18, 2005
Approved
Time to decision
141 days
Received Sep 30, 2004. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P950014-S023
- Device name
- PROSTATRON
- Applicant
- Urologix, Inc.
- Applicant location
- Plymouth, MN
- Received
- Sep 30, 2004
- Decided
- Feb 18, 2005
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Labeling Change - Indications/instructions/shelf life/tradename
- Original approval
- P950014
Device type
- Device class
- Class III
- Specialty
- GI, Urology & NephrologyUrology
FDA's approval statement
As written in FDA's record.
APPROVAL FOR MODIFICATION OF THE PROSTATRON LABELING REGARDING THE TREATMENT OF PATIENTS 1) WITH IMPLANTED ACTIVE DEVICES (INCLUDING PACEMAKERS AND DEFIBRILLATORS), 2) IN URINARY RETENTION, AND 3) WITH MEDIAN PROSTATIC LOBES.
Source documents
Other decisions for Urologix, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K142248 · Decided Feb 20, 2015 · 190 days after receipt
Device type: Electrosurgical, Cutting & Coagulation & Accessories (GEI) · General & Plastic Surgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.